The invention relates to enantiomerically pure compounds of formula (1), wherein the radicals R<;1>;, R<;2>;, R<;3>;, R4<; >;and X are defined as in claims and a description. A method for producing said compounds and the use thereof in the form of a drug, in particular as a drug for treating respiratory tract diseases are also disclosed. The synthesis of the compounds is carried out by means of a chiral epoxide of formula (5).